Cargando…

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis

BACKGROUND: Immucillins ImmA (IA), ImmH (IH) and SerMe-ImmH (SMIH) are synthetic deazapurine nucleoside analogues that inhibit Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis multiplication in vitro without macrophage toxicity. Immucillins are compared to the Glucantime standard dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freitas, Elisangela Oliveira, Nico, Dirlei, Alves-Silva, Marcus Vinícius, Morrot, Alexandre, Clinch, Keith, Evans, Gary B., Tyler, Peter C., Schramm, Vern L., Palatnik-de-Sousa, Clarisa B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689457/ https://www.ncbi.nlm.nih.gov/pubmed/26701750 http://dx.doi.org/10.1371/journal.pntd.0004297

Ejemplares similares

Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro
por: Freitas, Elisangela Oliveira, et al.
Publicado: (2015)

Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors
por: Nico, Dirlei, et al.
Publicado: (2012)

Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)

Re-measurement of $^{32}$Ar to test the IMME
por: Kreim, S
Publicado: (2012)

A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
por: Alves-Silva, Marcus Vinícius, et al.
Publicado: (2017)

VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013)

Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
por: Ilyinskii, Petr O., et al.
Publicado: (2021)

Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
por: Nico, Dirlei, et al.
Publicado: (2014)

ImmGen report: sexual dimorphism in the immune system transcriptome
por: Gal-Oz, Shani Talia, et al.
Publicado: (2019)

Adaptive Federated IMM Filter for AUV Integrated Navigation Systems
por: Lyu, Weiwei, et al.
Publicado: (2020)

Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis
por: Barbosa Santos, Micheli Luize, et al.
Publicado: (2017)

ImmTACs: Novel bi-specific agents for targeted cancer therapy
por: Oates, Joanne, et al.
Publicado: (2013)

An IMM-Aided ZUPT Methodology for an INS/DVL Integrated Navigation System
por: Yao, Yiqing, et al.
Publicado: (2017)

Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
por: Kishimoto, Takashi Kei
Publicado: (2020)

Breakdown of the Isobaric Multiplet Mass Equation (IMME) at A=33, T=3/2
por: Herfurth, F, et al.
Publicado: (2000)

Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis
por: Arcanjo, Angélica Fernandes, et al.
Publicado: (2017)

ImmTree: Database of evolutionary relationships of genes and proteins in the human immune system
por: Ortutay, Csaba, et al.
Publicado: (2007)

ImmGen Report: Molecular definition of Natural Killer cell identity and activation
por: Bezman, Natalie A., et al.
Publicado: (2012)

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
por: Bilyard, Hilary, et al.
Publicado: (2014)

LinkedImm: a linked data graph database for integrating immunological data
por: Bukhari, Syed Ahmad Chan, et al.
Publicado: (2021)

ImmReg: the regulon atlas of immune-related pathways across cancer types
por: Jiang, Tiantongfei, et al.
Publicado: (2021)

Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection
por: Nico, Dirlei, et al.
Publicado: (2014)

Immucillin-H, a purine nucleoside phosphorylase transition state analog, causes non-lethal attenuation of growth in Staphylococcus aureus
por: Stratton, Christopher F, et al.
Publicado: (2013)

Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
por: Nico, Dirlei, et al.
Publicado: (2015)

Organización administrativa y contable de un hospital de zona del IMMS.
por: Palacios López, Jose Luis
Publicado: (1987)

Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm
por: Woelke, Anna Lena, et al.
Publicado: (2011)

iMM1865: A New Reconstruction of Mouse Genome-Scale Metabolic Model
por: Khodaee, Saeideh, et al.
Publicado: (2020)

Improving the iMM904 S. cerevisiae metabolic model using essentiality and synthetic lethality data
por: Zomorrodi, Ali R, et al.
Publicado: (2010)

ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing
por: Donnellan, Zoe, et al.
Publicado: (2015)

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells
por: Boudousquie, Caroline, et al.
Publicado: (2017)

ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
por: Bhattacharya, Sanchita, et al.
Publicado: (2018)

ImmCluster: an ensemble resource for immunology cell type clustering and annotations in normal and cancerous tissues
por: Jiang, Tiantongfei, et al.
Publicado: (2022)

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis
por: Nico, Dirlei, et al.
Publicado: (2018)

Vaccines for Canine Leishmaniasis
por: Palatnik-de-Sousa, Clarisa B.
Publicado: (2012)

The Delay in the Licensing of Protozoal Vaccines: A Comparative History
por: Palatnik-de-Sousa, Clarisa Beatriz, et al.
Publicado: (2020)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
por: Dalgleish, Angus G, et al.
Publicado: (2016)

Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats
por: Zhang, Ziqian, et al.
Publicado: (2019)

A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases
por: Yang, Dongliang, et al.
Publicado: (2022)

ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases
por: Vetrano, Stefania, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oro3k0enlgjj4oa7a6amqipobu